Effects of Surface Pace in Baseball

A baseball travels across different surfaces at different paces. The goal of this experiment is to find a percentage difference in speeds the ball will reflect off a given surface. The ratio between the initial speeds and final speeds will be known as the coefficient of restitution and will be used to compare the pace of the two surfaces. In the Northwest Conference, NCAA Division III teams play on four turf-based infields and five dirt-based infields

Dust Storms in Space?

Primarily from the Pioneer 8 and 9 results, it is concluded that the flux of picogram sized dust particles near the earth's orbit has been constant to within the observational limits over three years of observation. In particular, since dust streams are not observed, they cannot explain microphone detected events. However, the possibility of rare events due to dust blown directly off a cometary nucleus (such as that reported for Comet Bennett) cannot be completely ruled out

Efficiency of aerosol collection on wires exposed in the stratosphere

The theory of inertial impaction is briefly presented. Stratospheric aerosol research experiments were performed duplicating Wong et al. experiments. The use of the curve of inertial parameters vs particle collection efficiency, derived from Wong et al., was found to be justified. The results show that stratospheric aerosol particles of all sizes are collectible by wire impaction technique. Curves and tables are presented and used to correct particle counts for collection efficiencies less than 100%

Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease

AIMS: To identify factors predicting improvement/stabilization on the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) and investigate whether early treatment responses can predict long-term outcomes, during a trial of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch in patients with severe Alzheimer's disease (AD). METHODS: Logistic regression was used to relate Week 24 ADCS-CGIC score to potential baseline predictors. Additional analyses based on receiver-operating characteristic curves were performed using Week 8/16 ADCS-CGIC scores to predict response (13.3 mg/24 h patch) at Week 24. ADCS-CGIC score of (1) 1-3 = "improvement," (2) 1-4 = "improvement or no change". RESULTS: "Treatment" (13.3 mg/24 h patch) and increased age were significant predictors of "improvement" (P = 0.01 and P = 0.003, respectively), and "treatment" (P = 0.001), increased age (P = 0.002), and prior AD treatment (P = 0.03) for "improvement or no change". At Week 8 and 16, ADCS-CGIC scores of 4 and 5 were optimal thresholds in predicting "improvement," and "improvement or no change," respectively, at Week 24. CONCLUSIONS: A significant therapeutic effect of high-dose rivastigmine patch on ADCS-CGIC response was observed. The 13.3 mg/24 h patch was identified as a predictor of "improvement" or "improvement or no change". Patients with minimal worsening/improvement/no change after treatment initiation may be more likely to respond following long-term therapy

Gladesville

Gladesville, situated on the northern banks of the Parramatta River approximately 10 kilometres from the city centre, adjoins the suburbs of Hunters Hill to the northeast, Boronia Park to the north, Ryde to the west and Tennyson Point to the southwest. Gladesville is divided between two local government areas: the City of Ryde (established in 1871) and the Municipality of Hunters Hill (established in 1861)

The genetics of dementia

Over the past decade, there has been a dramatic evolution of genetic methodologies that can be used to identify genes contributing to disease. Initially, the focus was primarily on classical linkage analysis; more recently, genomewide association studies, and high-throughput whole genome and whole exome sequencing have provided efficient approaches to detect common and rare variation contributing to disease risk. Application of these methodologies to dementias has led to the nomination of dozens of causative and susceptibility genes, solidifying the recognition that genetic factors are important contributors to the disease processes. In this review, the authors focus on current knowledge of the genetics of Alzheimer's disease and frontotemporal lobar degeneration. A working understanding of the genes relevant to common dementias will become increasingly critical, as options for genetic testing and eventually gene-specific therapeutics are developed

IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease

Our previous studies showed that intravenous immunoglobulin (IVIG) contained anti-Aβ autoantibodies that might be able to treat Alzheimer's disease (AD). Recently, we identified and characterized naturally occurring autoantibodies against PrP from IVIG. Although autoantibodies in IVIG blocked PrP fibril formation and PrP neurotoxicity in vitro, it remained unknown whether IVIG could reduce amyloid plaque pathology in vivo and be used to effectively treat animals with prion diseases. In this study, we used Gerstmann-Sträussler-Scheinker (GSS)-Tg (PrP-A116V) transgenic mice to test IVIG efficacy since amyloid plaque formation played an important role in GSS pathogenesis. Here, we provided strong evidence that demonstrates how IVIG could significantly delay disease onset, elongate survival, and improve clinical phenotype in Tg (PrP-A116V) mice. Additionally, in treated animals, IVIG could markedly inhibit PrP amyloid plaque formation and attenuate neuronal apoptosis at the age of 120 days in mice. Our results indicate that IVIG may be a potential, effective therapeutic treatment for GSS and other prion diseases